138 related articles for article (PubMed ID: 20032566)
1. Body mass index, fasting plasma glucose levels, and C-peptide levels as predictors of the future insulin use in Japanese type 2 diabetic patients.
Goto A; Takaichi M; Kishimoto M; Takahashi Y; Kajio H; Shimbo T; Noda M
Endocr J; 2010; 57(3):237-44. PubMed ID: 20032566
[TBL] [Abstract][Full Text] [Related]
2. A comparison of serum C-peptide response to intravenous glucagon, and urine C-peptide, as indexes of insulin dependence.
Matsuda A; Kamata I; Iwamoto Y; Sakamoto Y; Kuzuya T
Diabetes Res Clin Pract; 1985 Oct; 1(3):161-7. PubMed ID: 3915262
[TBL] [Abstract][Full Text] [Related]
3. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.
Boyko EJ; Fujimoto WY; Leonetti DL; Newell-Morris L
Diabetes Care; 2000 Apr; 23(4):465-71. PubMed ID: 10857936
[TBL] [Abstract][Full Text] [Related]
4. Parameters measuring beta-cell function are only valuable in diabetic subjects with low body mass index, high blood glucose level, or long-standing diabetes.
Lee SW; Lee S; Kim SH; Kim TH; Kang BS; Yoo SH; Lee MK; Koh WJ; Kang WS; Kim HJ
Yonsei Med J; 2011 Nov; 52(6):939-47. PubMed ID: 22028157
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Fasting C-Peptide Predicts Type 2 Diabetes Mellitus Remission in Low-BMI Chinese Patients After Roux-en-Y Gastric Bypass.
Zhao L; Li W; Su Z; Liu Y; Zhu L; Zhu S
J Gastrointest Surg; 2018 Oct; 22(10):1672-1678. PubMed ID: 29845572
[TBL] [Abstract][Full Text] [Related]
6. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
[TBL] [Abstract][Full Text] [Related]
7. Early Assessment of the Risk for Gestational Diabetes Mellitus: Can Fasting Parameters of Glucose Metabolism Contribute to Risk Prediction?
Falcone V; Kotzaeridi G; Breil MH; Rosicky I; Stopp T; Yerlikaya-Schatten G; Feichtinger M; Eppel W; Husslein P; Tura A; Göbl CS
Diabetes Metab J; 2019 Dec; 43(6):785-793. PubMed ID: 30877716
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with improvement of fasting plasma glucose level by mealtime dosing of a rapid-acting insulin analog in type 2 diabetes.
Takamura T; Sakurai M; Nakamura M; Shimizu A; Ota T; Misu H; Takeshita Y; Tsuchiyama N; Kurita S; Ando H; Kaneko S
Diabetes Res Clin Pract; 2007 Mar; 75(3):278-84. PubMed ID: 17069922
[TBL] [Abstract][Full Text] [Related]
9. Insulin response after treatment depends on fasting plasma glucose level in NIDDM.
Matsumoto K; Akazawa S; Abiru N; Yano M; Ishibasi M; Uotani S; Matsuo H; Kawasaki E; Yamasaki H; Yamamoto H
Diabetes Res Clin Pract; 1994 Dec; 26(2):129-35. PubMed ID: 7705194
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Fasting Plasma C-Peptide Levels as Predictors of Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: A Systematic Review and Meta-Analysis.
Yan W; Bai R; Yan M; Song M
J Invest Surg; 2017 Dec; 30(6):383-393. PubMed ID: 28045566
[TBL] [Abstract][Full Text] [Related]
11. Variation of endogenous insulin secretion in association with treatment status: assessment by serum C-peptide and modified urinary C-peptide.
Aoki Y
Diabetes Res Clin Pract; 1991 Dec; 14(3):165-73. PubMed ID: 1778109
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
[TBL] [Abstract][Full Text] [Related]
13. Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.
Saisho Y; Kou K; Tanaka K; Abe T; Kurosawa H; Shimada A; Meguro S; Kawai T; Itoh H
Endocr J; 2011; 58(4):315-22. PubMed ID: 21415555
[TBL] [Abstract][Full Text] [Related]
14. Relationship between β-cell function, metabolic control, and microvascular complications in type 2 diabetes mellitus.
Zhao L; Ma J; Wang S; Xie Y
Diabetes Technol Ther; 2015 Jan; 17(1):29-34. PubMed ID: 25574593
[TBL] [Abstract][Full Text] [Related]
15. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
[TBL] [Abstract][Full Text] [Related]
16. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.
Miyazaki Y; Mahankali A; Matsuda M; Glass L; Mahankali S; Ferrannini E; Cusi K; Mandarino LJ; DeFronzo RA
Diabetes Care; 2001 Apr; 24(4):710-9. PubMed ID: 11315836
[TBL] [Abstract][Full Text] [Related]
17. Levels of the first-phase insulin secretion deficiency as a predictor for type 2 diabetes onset by using clinical-metabolic models.
Lin JD
Ann Saudi Med; 2015; 35(2):138-45. PubMed ID: 26336020
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects.
Tanaka Y; Atsumi Y; Asahina T; Hosokawa K; Matsuoka K; Kinoshita J; Onuma T; Kawamori R
Diabetes Care; 1998 Jul; 21(7):1133-7. PubMed ID: 9653608
[TBL] [Abstract][Full Text] [Related]
19. Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes.
Toft-Nielsen MB; Madsbad S; Holst JJ
J Clin Endocrinol Metab; 2001 Aug; 86(8):3853-60. PubMed ID: 11502823
[TBL] [Abstract][Full Text] [Related]
20. Effect of insulin glargine on endogenous insulin secretion and beta-cell function in Japanese type 2 diabetic patients using oral antidiabetic drugs.
Ohta A; Kato H; Murayama K; Hashimoto E; Murakami M; Nishine A; Ohshige T; Sada Y; Asai S; Kawata T; Nagai Y; Katabami T; Tanaka Y
Endocr J; 2014; 61(1):13-8. PubMed ID: 24064478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
